Evidence map›Paper›PMID 33488943›Full record

ArticleOxidative medicine and cellular longevity2021

A Marine Terpenoid, Heteronemin, Induces Both the Apoptosis and Ferroptosis of Hepatocellular Carcinoma Cells and Involves the ROS and MAPK Pathways.

Wen-Tsan Chang, Yung-Ding Bow, Pei-Jung Fu, Chia-Yang Li, Chang-Yi Wu, Yi-Hua Chang, Yen-Ni Teng, Ruei-Nian Li, Mei-Chin Lu, Yi-Chang Liu and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 1 pooled it
15.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 1 synthesis or guideline pooled it, 128 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Targeting ferroptosis to overcome drug resistance in gastrointestinal cancers.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Wen-Tsan ChangDivision of General and Digestive Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.ORCID https://orcid.org/0000-0001-5622-8299
Yung-Ding BowPh.D. Program in Life Sciences, Kaohsiung Medical University, Kaohsiung 807, Taiwan.ORCID https://orcid.org/0000-0002-9270-2194
Pei-Jung FuDepartment of Biotechnology, Kaohsiung Medical University, Kaohsiung 807, Taiwan.ORCID https://orcid.org/0000-0002-4550-9535
Chia-Yang LiGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.ORCID https://orcid.org/0000-0001-5689-9850
Chang-Yi WuDepartment of Biotechnology, Kaohsiung Medical University, Kaohsiung 807, Taiwan.ORCID https://orcid.org/0000-0001-9760-5804
Yi-Hua ChangDepartment of Biotechnology, Kaohsiung Medical University, Kaohsiung 807, Taiwan.ORCID https://orcid.org/0000-0001-6734-4172
Yen-Ni TengDepartment of Biological Sciences and Technology, National University of Tainan, Tainan 700, Taiwan.ORCID https://orcid.org/0000-0002-3340-8577
Ruei-Nian LiDepartment of Biomedical Science and Environment Biology, Kaohsiung Medical University, Kaohsiung 807, Taiwan.ORCID https://orcid.org/0000-0003-2569-1314
Mei-Chin LuGraduate Institute of Marine Biotechnology, National Dong Hwa University, Pingtung 944, Taiwan.ORCID https://orcid.org/0000-0003-4335-3837
Yi-Chang LiuDivision of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.ORCID https://orcid.org/0000-0002-0681-3796
Chien-Chih ChiuCenter for Cancer Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.ORCID https://orcid.org/0000-0001-7307-2468
Kaohsiung Medical University · TWNational Sun Yat-sen University · TWNational Dong Hwa University · TWNational University of Tainan · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is a leading cause of death, resulting in over 700 thousand deaths annually worldwide. Chemotherapy is the primary therapeutic strategy for patients with late-stage HCC. Heteronemin is a marine natural product isolated from

Indexed as

FerroptosisAntineoplastic AgentsApoptosisCarcinoma, HepatocellularCell ProliferationGene Expression Regulation, NeoplasticHumansLiver NeoplasmsMAP Kinase Signaling SystemReactive Oxygen SpeciesTerpenesTumor Cells, CulturedAntineoplastic AgentsheteroneminReactive Oxygen SpeciesTerpenes

Identifiers

PMID33488943
PMCPMC7803406
OpenAlexW3118255995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.